Search clinical trials for: BMS-936558 (Anti-PD-1)
Total 6737 results
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Australia, Denmark, France, Switzerland, Austria, Canada, Germany, Japan, Netherlands, Norway, Spain, United Kingdom, Finland, Italy
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
Bristol-Myers SquibbCompletedHematologic NeoplasmsUnited States, Canada
-
Bristol-Myers SquibbCompletedNeoplasms by SiteUnited States
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Bristol-Myers SquibbCompletedAdvanced TumorsUnited States, France, Australia, Spain, Canada
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
Shanghai Zhongshan HospitalRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)CompletedGlioblastoma | Gliosarcoma | Recurrent Brain NeoplasmUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI); Cancer League of ColoradoWithdrawnColorectal Cancer | Microsatellite Instability High | Mismatch Repair DeficiencyUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal Carcinoma | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
Capital Medical UniversityDuke UniversityCompleted
-
Capital Medical UniversityDuke University; Geneplus-Beijing Co. Ltd.CompletedNeoplasms | Lung CancerChina
-
Centre Leon BerardNETRIS PharmaRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsFrance
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
John KirkwoodBristol-Myers SquibbActive, not recruiting
-
Dana-Farber Cancer InstituteStand Up To CancerActive, not recruitingLymphoma | Solid Tumor, Childhood | Brain Tumor, PediatricUnited States, Canada
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
CureVacSyneos Health; Cromos Pharma LLCActive, not recruitingCarcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and NeckSpain, France, Austria, Germany, Russian Federation
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Istari Oncology, Inc.Active, not recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate CancerUnited States
-
PfizerActive, not recruitingRenal Cell Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Bile Duct Cancer | Endometrial Cancer | Urothelial Cancer | Lung Squamous Cell Carcinoma | Melanoma CancerUnited States, Taiwan, Korea, Republic of, Australia, Slovakia
-
Waterstone Hanxbio Pty LtdCompletedAdvanced Solid TumorAustralia
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompletedMelanoma (Skin)United States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
RWJ Barnabas Health at Jersey City Medical CenterUnknown
-
Agenus Inc.CompletedCervical Cancer | Advanced CancerFrance, United States, Belgium, Australia, Spain, Estonia, Brazil, Chile, Poland
-
The First Affiliated Hospital of Guangdong Pharmaceutical...Guangzhou Anjie Biomedical Technology Co., Ltd.Unknown
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Edward KimBristol-Myers Squibb; National Cancer Institute (NCI)TerminatedUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma... and other conditionsUnited States
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co....UnknownNon-small Cell Lung Cancer | Lung Neoplasm MalignantChina
-
OncoC4, Inc.Avance Clinical; OncoC4 AU Pty LtdRecruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Fallopian Tube Cancer | Non Small Cell Lung Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Primary Peritoneal... and other conditionsAustralia
-
Cancer Hospital of Guangxi Medical UniversityRecruitingNasopharyngeal Carcinoma | SintilimabChina
-
Tongji HospitalNational Natural Science Foundation of ChinaRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant TherapiesChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
University Hospital Southampton NHS Foundation...University College London Hospitals; University of Wisconsin, Madison; University... and other collaboratorsRecruitingNeuroblastomaUnited Kingdom, United States
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Sinocelltech Ltd.UnknownHead and Neck Squamous Cell CarcinomaChina
-
Thomas MarronRecruiting
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Small Cell Lung CancerMexico
-
Henlix, IncUnknown
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedSolid TumorUnited States